People living with chronic pain due to sickle cell disease should be managed with a variety of pharmacologic and nonpharmacologic strategies, ranging from opioid therapy to acupuncture, depending on the individual patient’s needs, according to new guidelines released by the American Society of Hematology.
However, many modalities do not have strong evidence in the literature to suggest them to all patients, according to the